Company News-Keysee Medtech

Six Major Investment Directions for Innovative Medical Devices

Six Major Investment Directions for Innovative Medical Devices

Driven by a confluence of favorable policies, rising demand quality, advancements in manufacturing capabilities, technological innovation, and capital investment, the medical device industry has emerged as the fastest-growing segment within the health sector—and one of the most promising investment hotspots in the capital markets.

01

2025

/

03

Development of Novel Drug Delivery Systems Enhances Therapeutic Efficacy

Development of Novel Drug Delivery Systems Enhances Therapeutic Efficacy

The development of novel drug-delivery systems has emerged as a new hotspot in pharmaceutical R&D. Researchers are dedicated to creating more efficient and precise methods for drug delivery, such as nano-targeted delivery systems and smart-responsive delivery systems.

01

2025

/

03

Policy Incentives Drive the Thriving Innovation and R&D of Traditional Chinese Medicine

Policy Incentives Drive the Thriving Innovation and R&D of Traditional Chinese Medicine

The state has introduced a series of policies and measures to encourage innovation and R&D in traditional Chinese medicine, injecting strong momentum into the development of the TCM industry.

01

2025

/

03

Policy Support Accelerates Innovative Drug Development

Policy Support Accelerates Innovative Drug Development

Recently, the General Office of the State Council issued the “Opinions on Comprehensively Deepening Regulatory Reform of Pharmaceuticals and Medical Devices to Promote High-Quality Development of the Pharmaceutical Industry,” injecting strong momentum into the development of the pharmaceutical sector.

13

2024

/

05

The pharmaceutical sector continues to rally, with innovation and international expansion serving as key drivers.

The pharmaceutical sector continues to rally, with innovation and international expansion serving as key drivers.

This week, the pharmaceutical and biotechnology index rose by 1.88%, outperforming the CSI 300 Index by 0.87 percentage points, with year-to-date gains reaching 3.93%. Sub-sectors such as pharmaceutical R&D outsourcing, hospitals, and medical equipment delivered particularly strong performance.

02

2023

/

03

< 1 2 >

Keysee

Polymer tubing

Intervention in consumables OEM

Company Profile
Culture

Neuro Intervention

Peripheral Intervention

Cardiovascular Intervention

Contact Information

IMFORMATION

Contact: Manager Zhang

Tel: +86 15026990525
Email: mkt001@keyseemed.com
Address: No. Y6, Lane 18, Weihang Road, Baoshan District, Shanghai

Contact: Manager Huang
Tel: +86 18795457598
Email: mkt002@keyseemed.com
Address: Building 1, No. 300, Baichuan Road, Haian High-tech Zone

Business license

Jiangsu Keysee Medical Technology Co., Ltd. 丨SEO

Power By 300.cn